{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T09:42:19Z","timestamp":1791538939705,"version":"4.3.4"},"reference-count":79,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0227945","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T13:36:52Z","timestamp":1580305012000},"page":"e0227945","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["The cost-effectiveness of using pneumococcal conjugate vaccine (PCV13) versus pneumococcal polysaccharide vaccine (PPSV23), in South African adults"],"prefix":"10.1371","volume":"15","author":[{"given":"Charles","family":"Feldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sipho K.","family":"Dlamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabir A.","family":"Madhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Meiring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"von Gottberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7438-5201","authenticated-orcid":true,"given":"Janetta C.","family":"de Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet","family":"de Necker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marthinus P.","family":"Stander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"issue":"11","key":"pone.0227945.ref001","article-title":"Adult pneumococcal vaccination guideline","volume":"89","author":"SAMA-SA Pulmonology Society Working Group","year":"1999","journal-title":"SAMJ"},{"key":"pone.0227945.ref002","unstructured":"World Health Organization (WHO). Immunization, Vaccines and Biologicals: Pneumococcal disease. Available from: http:\/\/www.who.int\/immunization\/diseases\/pneumococcal\/en\/ Cited 12 February 2018."},{"key":"pone.0227945.ref003","unstructured":"Centers for Disease Control and Prevention. Pneumococcal Disease: Types of Infection. Available from: https:\/\/www.cdc.gov\/pneumococcal\/about\/infection-types.html Cited 12 February 2018."},{"issue":"2","key":"pone.0227945.ref004","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jinf.2010.04.008","article-title":"The risk of sequelae due to pneumococcal meningitis in high-income countries: a systematic review and meta-analysis","volume":"61","author":"M Jit","year":"2010","journal-title":"J Infect"},{"issue":"2","key":"pone.0227945.ref005","first-page":"15","article-title":"An update on pneumococcal vaccination in children and adults","volume":"81","author":"J Souter","year":"2014","journal-title":"S Afr Pharm J"},{"key":"pone.0227945.ref006","unstructured":"Pfizer Laboratories. Prevenar 13\u00ae Package Insert. 26 November 2015."},{"key":"pone.0227945.ref007","unstructured":"Department of Health, Republic of South Africa. Vaccinator\u2019s Manual: \u2018Immunization that works\u2019. Expanded Programme on Immunisation in South Africa. Available from: http:\/\/pharmadynamics.co.za\/wp-content\/uploads\/2016\/11\/VaccinatorsManualFinal.pdf Cited 12 February 2018."},{"key":"pone.0227945.ref008","first-page":"e244","article-title":"13-valent pneumococcal conjugate vaccine in Africa","volume":"5","author":"R Cohen","year":"2017","journal-title":"Lancet"},{"key":"pone.0227945.ref009","unstructured":"Department of Health, Republic of South Africa. HIV and AIDS, TB, Maternal, Child and Women\u2019s Health. 2nd Triennial Report of the Committee on Morbidity and Mortality in Children Under 5 Years: 2014. Available from: http:\/\/www.health.gov.za\/index.php\/hiv-aids-tb-and-maternal-and-child-health# Cited 12 February 2018."},{"key":"pone.0227945.ref010","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.12688\/f1000research.9283.1","article-title":"Epidemiology, virulence factors and management of the pneumococcus","volume":"5","author":"C. Feldman","year":"2016","journal-title":"F1000Res"},{"issue":"11","key":"pone.0227945.ref011","doi-asserted-by":"crossref","first-page":"e27929","DOI":"10.1371\/journal.pone.0027929","article-title":"Persistent High Burden of Invasive Pneumococcal Disease in South African HIV-Infected Adults in the Era of an Antiretroviral Treatment Program","volume":"6","author":"MC Nunes","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"pone.0227945.ref012","doi-asserted-by":"crossref","first-page":"e0149104","DOI":"10.1371\/journal.pone.0149104","article-title":"HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV)","volume":"11","author":"S Meiring","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"pone.0227945.ref013","doi-asserted-by":"crossref","first-page":"e0140185","DOI":"10.1371\/journal.pone.0140185","article-title":"Streptococcus pneumoniae Serotypes and Mortality in Adults and Adolescents in South Africa: Analysis of National Surveillance Data, 2003\u20132008","volume":"10","author":"C Cohen","year":"2015","journal-title":"PLoS One"},{"issue":"9221","key":"pone.0227945.ref014","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(00)02377-1","article-title":"23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial","volume":"355","author":"N French","year":"2000","journal-title":"Lancet"},{"issue":"8","key":"pone.0227945.ref015","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1097\/00002030-200405210-00018","article-title":"23-Valent pneumococcal polysaccharide vaccine in HIV-infected Ugandan adults: 6-year follow-up of a clinical trial cohort","volume":"18","author":"C Watera","year":"2004","journal-title":"AIDS"},{"issue":"9","key":"pone.0227945.ref016","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJMoa0903029","article-title":"A trial of 7-valent pneumococcal conjugate vaccine in HIV-infected adults","volume":"362","author":"N French","year":"2010","journal-title":"N Engl J Med"},{"key":"pone.0227945.ref017","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults","volume":"372","author":"MJM Bonten","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0227945.ref018","first-page":"1469","article-title":"South African guideline for the management of community-acquired pneumonia in adults","volume":"9","author":"TH Boyles","year":"2017"},{"key":"pone.0227945.ref019","unstructured":"USAID, PEPFAR, Health Policy Project. Health Financing Profile: South Africa. May 2016. Available from: http:\/\/www.who.int\/tobacco\/global_report\/2015\/report\/en\/ Cited 20 September 2019."},{"issue":"5","key":"pone.0227945.ref020","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1183\/13993003.00325-2015","article-title":"Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands","volume":"46","author":"MJ Mangen","year":"2015","journal-title":"Eur Respir J"},{"key":"pone.0227945.ref021","unstructured":"World Health Organization. Tobacco Free Initiative. WHO Report on the Global Tobacco Epidemic, 2015. Available from: http:\/\/www.who.int\/tobacco\/global_report\/2015\/report\/en\/ Cited 12 February 2018."},{"key":"pone.0227945.ref022","unstructured":"World Health Organization. Global Health Observatory data. South Africa: country profiles. Alcohol Consumption: levels and patterns. 2014. Available from: http:\/\/www.who.int\/gho\/countries\/zaf\/country_profiles\/en\/ Cited 12 February 2018."},{"key":"pone.0227945.ref023","unstructured":"University of Pretoria. Speech-Language Pathology and Audiology: Cochlear Implant Unit. Available from: http:\/\/www.up.ac.za\/speech-language-pathology-and-audiology\/article\/40919\/cochlear-implant-unit Cited 12 February 2018."},{"key":"pone.0227945.ref024","unstructured":"National Institute for Communicable Diseases. National Cancer Registry. Cancer in South Africa Full Reports for 2000 through to 2012. Available from: http:\/\/www.nicd.ac.za\/index.php\/centres\/national-cancer-registry\/ Cited 12 February 2018."},{"key":"pone.0227945.ref025","unstructured":"Organ Donor Foundation of South Africa. Transplant Statistics in South Africa in 2016. Available from: https:\/\/www.odf.org.za Cited 12 February 2018."},{"key":"pone.0227945.ref026","first-page":"36118","volume-title":"Guidelines for Pharmacoeconomic submission","author":"Department of Health, Republic of South Africa","year":"2013"},{"key":"pone.0227945.ref027","unstructured":"World Health Organization. The world health report 2002: reducing risks, promoting healthy life. Available from: http:\/\/www.who.int\/whr\/2002\/en\/ Cited 12 February 2018."},{"issue":"1","key":"pone.0227945.ref028","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1478-7547-1-8","article-title":"Generalized cost-effectiveness analysis for national-level priority-setting in the health sector","volume":"1","author":"R Hutubessy","year":"2003","journal-title":"Cost Eff Resour Alloc"},{"key":"pone.0227945.ref029","unstructured":"World Health Organization. Cost effectiveness and strategic planning (WHO-CHOICE). AFR D: cost effectiveness results for malaria. 2014. Available from: http:\/\/www.who.int\/choice\/results\/mal_afrd\/en\/ Cited 12 February 2018."},{"issue":"2","key":"pone.0227945.ref030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40273-012-0011-8","article-title":"Cost-effectiveness acceptability curves revisited","volume":"31","author":"MJ Al","year":"2013","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"pone.0227945.ref031","article-title":"The modified Delphi technique\u2013a rotational modification","volume":"15","author":"RL Custer","year":"1999","journal-title":"CTE J"},{"issue":"1","key":"pone.0227945.ref032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-1647(76)90094-0","article-title":"The prediction of air travel and aircraft technology to the year 2000 using the Delphi method","volume":"10","author":"GM English","year":"1976","journal-title":"Transportation Research"},{"key":"pone.0227945.ref033","unstructured":"Council for Medical Schemes. Annual Report 2016\u20132016 Annexures. Available from: https:\/\/www.medicalschemes.com\/files\/Annual%20Reports\/CMS%20Annual%20Report%202015-2016%20Annexures.pdf Cited 5 March 2018."},{"key":"pone.0227945.ref034","unstructured":"Statistics South Africa. Mid-year population estimates 2014. Statistical release P0302. Available from: https:\/\/www.statssa.gov.za\/publications\/P0302\/P03022014.pdf Cited 12 February 2018."},{"key":"pone.0227945.ref035","unstructured":"Council for Medical Schemes. Annual Report 2013\/2014. Available from: https:\/\/www.medicalschemes.com\/files\/Annual%20Reports\/AR2013_2014LR.pdf Cited 12 February 2018."},{"key":"pone.0227945.ref036","unstructured":"Actuarial Society of South Africa. AIDS models: ASSA 2008. Available from: http:\/\/www.actuarialsociety.org.za\/committees\/demography-epidemiology-committee\/aids-models\/ Cited 12 February 2018."},{"issue":"3","key":"pone.0227945.ref037","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/431521","article-title":"The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults","volume":"192","author":"MH Kyaw","year":"2005","journal-title":"J Infect Dis"},{"key":"pone.0227945.ref038","unstructured":"Statistics South Africa. Mortality and causes of death in South Africa, 2014: Findings from death notification. Statistical release P0309.3. Available from: http:\/\/www.statssa.gov.za\/publications\/P03093\/P030932014.pdf Cited 12 February 2018."},{"key":"pone.0227945.ref039","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/1471-2334-12-277","article-title":"Mortality in members of HIV-1 serodiscordant couples in Africa and implications for antiretroviral therapy initiation: results of analyses from a multicenter randomized trial","volume":"12","author":"G De Bruyn","year":"2012","journal-title":"BMC Infect Dis"},{"key":"pone.0227945.ref040","unstructured":"Naidoo N. Streptococcus pneumoniae serotypes and mortality in adults in South Africa: Analysis of national surveillance data (2003\u20132008). M.Sc. Thesis. University of the Witwatersrand. 2014. Available from: http:\/\/wiredspace.wits.ac.za\/handle\/10539\/15423."},{"issue":"9","key":"pone.0227945.ref041","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1017\/S0950268810002402","article-title":"Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumoniae","volume":"139","author":"S Lin","year":"2011","journal-title":"Epidemiol Infect"},{"key":"pone.0227945.ref042","unstructured":"Centers for Disease Control and Prevention. National Center for Health Statistics. Mortality data from the National Vital Statistics System. 2009. Available from: http:\/\/www.cdc.gov\/nchs\/deaths.htm. Cited 17 August 2009."},{"key":"pone.0227945.ref043","doi-asserted-by":"crossref","first-page":"960","DOI":"10.7326\/0003-4819-138-12-200306170-00007","article-title":"Cost-Effectiveness of Vaccination against Invasive Pneumococcal Disease among People 50 through 64 Years of Age: Role of Comorbid Conditions and Race","volume":"138","author":"JE Sisk","year":"2003","journal-title":"Ann Intern Med"},{"issue":"31\u201332","key":"pone.0227945.ref044","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.vaccine.2004.05.003","article-title":"Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales","volume":"22","author":"A Melegaro","year":"2004","journal-title":"Vaccine"},{"key":"pone.0227945.ref045","article-title":"Pneumococcal disease: a systematic review of health utilities, resource use, costs, and economic evaluations of interventions","author":"T Shiri","year":"2019","journal-title":"Value Health"},{"key":"pone.0227945.ref046","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.vaccine.2008.01.007","article-title":"Alternative strategies for adult pneumococcal polysaccharide vaccination: a cost-effective analysis","volume":"26","author":"KJ Smith","year":"2008","journal-title":"Vaccine"},{"key":"pone.0227945.ref047","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJM199111213252101","article-title":"The protective efficacy of polyvalent pneumococcal polysaccharide vaccine","volume":"325","author":"ED Shapiro","year":"1991","journal-title":"N Engl J Med"},{"key":"pone.0227945.ref048","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0264-410X(02)00451-6","article-title":"Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly","volume":"21","author":"AM Fry","year":"2002","journal-title":"Vaccine"},{"key":"pone.0227945.ref049","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of 9-valent pneumococcal vaccine in children with and those without HIV infection","volume":"349","author":"K Klugman","year":"2003","journal-title":"N Engl J Med"},{"key":"pone.0227945.ref050","unstructured":"Free Currency Rates. United States dollar (USD) and South African rand (ZAR) year 2015 Exchange Rate History. Available from: https:\/\/freecurrencyrates.com\/en\/exchange-rate-history\/USD-ZAR\/2015 Cited 15 October 2019."},{"issue":"1","key":"pone.0227945.ref051","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/10158782.2013.11441513","article-title":"Guidelines for the management of acute meningitis in children and adults in South Africa","volume":"28","author":"T Boyles","year":"2013","journal-title":"Southern African Journal of Epidemiology and Infection"},{"issue":"14","key":"pone.0227945.ref052","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1097\/QAD.0000000000000385","article-title":"Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection","volume":"28","author":"A Bamford","year":"2014","journal-title":"AIDS"},{"key":"pone.0227945.ref053","volume-title":"Counting the cost of meningitis: a severe case of bacterial meningitis","author":"C Wright","year":"2011"},{"issue":"3","key":"pone.0227945.ref054","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1128\/CMR.00070-09","article-title":"Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis","volume":"23","author":"MC Brouwer","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"37","key":"pone.0227945.ref055","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1016\/j.vaccine.2013.06.037","article-title":"Cost-effectiveness of pneumococcal conjugate vaccination in immunocompromised adults","volume":"31","author":"KJ Smith","year":"2013","journal-title":"Vaccine"},{"key":"pone.0227945.ref056","unstructured":"South African Medicine Price Registry. Database of Medicine Prices. Available from: http:\/\/www.mpr.gov.za\/PublishedDocuments.aspx#DocCatId=21 Cited 12 February 2018."},{"key":"pone.0227945.ref057","unstructured":"Department of Health, Republic of South Africa. Uniform patient fee schedule for paying patients attending public hospitals. April 2015 Available from: http:\/\/www.health.gov.za\/index.php\/shortcodes\/2015-03-29-10-42-47\/2015-04-30-09-10-23\/uniform-patient-fee-schedule\/category\/282-u2016 Cited 12 February 2018."},{"issue":"6","key":"pone.0227945.ref058","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/rheumatology\/keq399","article-title":"Quantifying the economic burden of productivity loss in rheumatoid arthritis","volume":"50","author":"I Filipovic","year":"2011","journal-title":"Rheumatology"},{"key":"pone.0227945.ref059","doi-asserted-by":"crossref","unstructured":"Levinsohn JA, McLaren Z, Shisana O, Zuma K. HIV status and labor market participation in South Africa. NBER Working Paper No. 16901. March 2011. JEL No. O12. Available from: http:\/\/www.nber.org\/papers\/w16901 Cited 12 February 2018.","DOI":"10.3386\/w16901"},{"key":"pone.0227945.ref060","unstructured":"Presence C. R69bn: four-year NHI price tag. Pressreader Pretoria news. 30 June 2017. Available from: https:\/\/www.pressreader.com\/south-africa\/pretoria-news\/20170630\/281715499632148 Cited 12 February 2018."},{"issue":"5","key":"pone.0227945.ref061","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.jval.2011.05.007","article-title":"Estimation and Comparison of EQ-5D Health States\u2019 Utility Weights for Pneumoccocal and Human Papillomavirus Diseases in Argentina, Chile, and the United Kingdom","volume":"14","author":"J Galante","year":"2011","journal-title":"Value Health"},{"key":"pone.0227945.ref062","unstructured":"South African Medicine Price Registry. Database of Medicine Prices. Available from: http:\/\/www.mpr.gov.za\/PublishedDocuments.aspx#DocCatId=21 Cited 22 October 2018."},{"key":"pone.0227945.ref063","unstructured":"Master Procurement Catalogue. National department of health. Available from: http:\/\/www.health.gov.za\/ Cited 5 October 2018."},{"key":"pone.0227945.ref064","unstructured":"Statistics South Africa. Mid-year population estimates 2019. Available from: http:\/\/www.statssa.gov.za\/publications\/P0302\/P03022019.pdf Cited 14 October 2019."},{"issue":"4","key":"pone.0227945.ref065","doi-asserted-by":"crossref","first-page":"e1001418","DOI":"10.1371\/journal.pmed.1001418","article-title":"Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies","volume":"10","author":"LF Johnson","year":"2013","journal-title":"PLoS Med"},{"issue":"1","key":"pone.0227945.ref066","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40261-015-0345-z","article-title":"Cost effectiveness of the 13-valent pneumococcal conjugate vaccination program in chronic obstructive pulmonary disease patients aged 50+ years in Spain","volume":"36","author":"JM Rodr\u00edguez Gonz\u00e1lez-Moro","year":"2016","journal-title":"Clin Drug Investig"},{"key":"pone.0227945.ref067","unstructured":"Sculpher M. The use of a probabilistic sensitivity analysis for decision making: the example of drug-eluting stents. Available from: https:\/\/www.york.ac.uk\/media\/che\/documents\/papers\/presentations\/teehtacosteff04.pdf Cited 14 October 2019."},{"issue":"4","key":"pone.0227945.ref068","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/21645515.2015.1011954","article-title":"A review of economic evaluations of 13-valent pneumococcal conjugate vaccine (PCV13) in adults and the elderly","volume":"11","author":"S Dirmesropian","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"18","key":"pone.0227945.ref069","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.vaccine.2016.03.003","article-title":"The cost-effectiveness of pneumococcal vaccination in healthy adults over 50: An exploration of influential factors for Belgium","volume":"34","author":"A Blommaert","year":"2016","journal-title":"Vaccine"},{"issue":"10","key":"pone.0227945.ref070","doi-asserted-by":"crossref","first-page":"e0139140","DOI":"10.1371\/journal.pone.0139140","article-title":"Economic Evaluation of Immunisation Programme of 23-Valent Pneumococcal Polysaccharide Vaccine and the Inclusion of 13-Valent Pneumococcal Conjugate Vaccine in the List for Single-Dose Subsidy to the Elderly in Japan","volume":"10","author":"SL Hoshi","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"pone.0227945.ref071","first-page":"444","article-title":"Cost-effectiveness analysis in regard to elderly person in Japan, of PCV13 and PPV23 sequential dosing against PPV23 single dose as the routine vaccination program","volume":"25","author":"A Watanabe","year":"2015","journal-title":"Respiratory Medicine (Japanese)"},{"issue":"5","key":"pone.0227945.ref072","doi-asserted-by":"crossref","first-page":"e0177342","DOI":"10.1371\/journal.pone.0177342","article-title":"Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea","volume":"12","author":"JY Heo","journal-title":"PLoS ONE"},{"key":"pone.0227945.ref073","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.vhri.2018.09.005","article-title":"Cost-utility study of PCV13 versus PPSV23 in adults in Chile","volume":"17","author":"L Biagini","year":"2018","journal-title":"Value Health Reg Issues"},{"issue":"8","key":"pone.0227945.ref074","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s11606-016-3651-0","article-title":"Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the United States","volume":"31","author":"C Stoecker","year":"2016","journal-title":"J Gen Intern Med"},{"issue":"2","key":"pone.0227945.ref075","doi-asserted-by":"crossref","first-page":"e0149540","DOI":"10.1371\/journal.pone.0149540","article-title":"Cost-Effectiveness of Vaccinating Immunocompetent \u226565 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England","volume":"11","author":"AJ Van Hoek","year":"2016","journal-title":"PLoS One"},{"key":"pone.0227945.ref076","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.trivac.2016.04.004","article-title":"A post hoc assessment of duration of protection in CAPiTA (Community Acquired Pneumonia immunization Trial in Adults)","volume":"5","author":"S Patterson","year":"2016","journal-title":"Trials Vaccinol"},{"issue":"10","key":"pone.0227945.ref077","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses","volume":"316","author":"G Sanders","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"pone.0227945.ref078","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s40273-019-00805-5","article-title":"Cost effectiveness of elderly pneumococcal vaccination in presence of higher-valent pneumococcal conjugate childhood vaccination: systematic literature review with focus on methods and assumptions","volume":"37","author":"M Treskova","year":"2019","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"pone.0227945.ref079","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12955-017-0694-9","article-title":"International comparison of experience-based health state values at the population level","volume":"15","author":"R Heijink","year":"2017","journal-title":"Health Qual Life Outcomes"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227945","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T13:37:45Z","timestamp":1580305065000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227945"}},"subtitle":[],"editor":[{"given":"Isabelle","family":"Durand-Zaleski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0227945","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,29]]}}}